Comprehensive Analysis of the Prognostic Significance of the TRIM Family in the Context of TP53 Mutations in Cancers

被引:2
|
作者
Vu, Trung [1 ]
Fowler, Annaliese [2 ]
McCarty, Nami [2 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med Prevent Human Dis IMM, Ctr Stem Cell & Regenerat Dis, Houston, TX 77030 USA
[2] Texas A&M Univ, Dept Biomed Engn, Houston, TX 77030 USA
关键词
TP53; liver cancer; TRIM family; cell cycle; HEPATOCELLULAR-CARCINOMA; CELL-PROLIFERATION; GENE-EXPRESSION; P53; MICRORNAS; SURVIVAL; PROMOTES; MIR-34A;
D O I
10.3390/cancers15153792
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary The p53 protein is an important tumor suppressor, and TP53 mutations are frequently low survival rates of cancer patients. Mutations in TP53 lead in loss of tumor suppressing functions which result in the development of tumors. Meanwhile, several tripartite motif (TRIM) proteins are known to regulate cell growth and cell cycle transition. However, the relationship between TRIM family genes and TP53 mutations in cancer remains unknown. In this study, we analyzed the links between TP53 mutations and TRIM family proteins and evaluated the role of TRIM family proteins in cancer patients with TP53 mutation. Our findings identified the TRIM family members that are highly expressed in TP53 mutant tumors and important for the cell growth in the context of TP53 mutations. The p53 protein is an important tumor suppressor, and TP53 mutations are frequently associated with poor prognosis in various cancers. Mutations in TP53 result in a loss of p53 function and enhanced expression of cell cycle genes, contributing to the development and progression of cancer. Meanwhile, several tripartite motif (TRIM) proteins are known to regulate cell growth and cell cycle transition. However, the prognostic values between TP53 and TRIM family genes in cancer are unknown. In this study, we analyzed the relationship between the TP53 mutations and TRIM family proteins and evaluated the prognostic significance of TRIM family proteins in cancer patients with P53 mutations. Our findings identified specific TRIM family members that are upregulated in TP53 mutant tumors and are associated with the activation of genes related to a cell-cycle progression in the context of TP53 mutations.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Relative frequency and morphology of cancers in carriers of germline TP53 mutations
    Birch, JM
    Alston, RD
    McNally, RJQ
    Evans, DGR
    Kelsey, AM
    Harris, M
    Eden, OB
    Varley, JM
    ONCOGENE, 2001, 20 (34) : 4621 - 4628
  • [32] Comprehensive analysis of TP53 and SPOP mutations and their impact on survival in metastatic prostate cancer
    Zhou, Jie
    Lai, Yiming
    Peng, Shengmeng
    Tang, Chen
    Chen, Yongming
    Li, Lingfeng
    Huang, Hai
    Guo, Zhenghui
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [33] Analysis of TP53 mutations in human malignant gliomas
    Sylvia Norman
    Adrienne Scheck
    Jeff Braman
    Nature Genetics, 2001, 27 (Suppl 4) : 76 - 76
  • [34] SIGNIFICANCE OF LOCUS-SPECIFIC TP53 MUTATIONS IN OVARIAN CANCER
    Knoll, K.
    Berger, A.
    Tsibulak, I.
    Leitner, K.
    Degasper, C.
    Welponer, H.
    Wieser, V.
    Marth, C.
    Fiegl, H.
    Zeimet, A-G
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A139 - A139
  • [35] TP53 mutations and microsatellite instability are prognostic factors in gastric cancer?
    Corsale, S.
    Agnese, V.
    Augello, C.
    Bruno, L.
    Calcara, D.
    Calo, V.
    Gargano, G.
    Gregorio, V.
    Gullo, A.
    La Paglia, L.
    Schiro, V.
    Terrasi, M.
    Crosta, A.
    Rinaldi, G.
    Tomasino, R. M.
    Morello, V.
    Daniele, E.
    Pantuso, G.
    Fiorentino, E.
    Chiarini, A.
    Martorana, A.
    Bazan, V.
    Russo, A.
    ANNALS OF ONCOLOGY, 2006, 17 : VII148 - VII149
  • [36] PROGNOSTIC VALUE OF TP53 MUTATIONS IN SHH TYPE OF PEDIATRIC MEDULLOBLASTOMA
    Trubicka, Joanna
    Borucka-Mankiewicz, Maria
    Ciara, Elzbieta
    Chrzanowska, Krystyna
    Perek-Polnik, Marta
    Abramczuk-Piekutowska, Dorota
    Grajkowska, Wieslawa
    Jurkiewicz, Dorota
    Luczak, Sylwia
    Kowalski, Pawel
    Krajewska-Walasek, Malgorzata
    Lastowska, Maria
    NEURO-ONCOLOGY, 2014, 16 : 76 - 77
  • [37] The prognostic value of TP53 mutations in hypopharyngeal squamous cell carcinoma
    Go Omura
    Mizuo Ando
    Yasuhiro Ebihara
    Yuki Saito
    Kenya Kobayashi
    Osamu Fukuoka
    Ken Akashi
    Masafumi Yoshida
    Takahiro Asakage
    Tatsuya Yamasoba
    BMC Cancer, 17
  • [39] The prognostic value of TP53 mutations in hypopharyngeal squamous cell carcinoma
    Omura, Go
    Ando, Mizuo
    Ebihara, Yasuhiro
    Saito, Yuki
    Kobayashi, Kenya
    Fukuoka, Osamu
    Akashi, Ken
    Yoshida, Masafumi
    Asakage, Takahiro
    Yamasoba, Tatsuya
    BMC CANCER, 2017, 17
  • [40] Prognostic value of mutations in TP53 and RAS genes in breast cancer
    Guerra, E
    Vacca, G
    Palombo, B
    Alberti, S
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2003, 18 (01): : 49 - 53